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Abstract
Introduction
Research suggests aerosol from electronic vapor products (EVPs)
has fewer harmful constituents than conventional cigarette smoke.
Even so, EVPs and other nicotine-containing products are not safe
to use during pregnancy. We examined perceptions among US
adults regarding harm in using EVPs rather than smoking cigar-
ettes during pregnancy.
Methods
Data came from the 2015 Styles Survey, an Internet panel survey
of a sample of US adults aged 18 years or older  (N = 4,127). Per-
ceived harm was assessed by asking respondents whether using
EVPs was less, equally, or more harmful for pregnant women than
smoking cigarettes. Descriptive statistics were used to estimate
perceived harm overall and by sociodemographic characteristics
and tobacco-use status. Perceived harm was assessed among all
adults, women of reproductive age (18–44 years, n = 820), and
women of nonreproductive age (≥45 years, n = 1,398).
Results
Among all adults, 11.1% believed using EVPs during pregnancy
was less harmful than smoking conventional cigarettes, 51.0% be-
lieved it was equally harmful, 11.6% believed it was more harm-
ful,  and 26.2% did not know. Prevalence of perception of less
harm, by demographic category, was greatest among adults aged
18 to 24 years, men, non-Hispanic whites, adults with less than a
high school diploma, current  EVP users,  and current  cigarette
smokers (P < .05).  Prevalence of  perception of  less  harm was
greater among women of reproductive age (9.6%) than among
those of nonreproductive age (7.9%) (P < .05).
Conclusion
US adults have varying levels of perceptions about the harms of
EVP use versus cigarette smoking during pregnancy. Efforts are
warranted to prevent nicotine exposure during pregnancy and to
educate adults on the dangers of using any form of tobacco during
pregnancy, including EVPs.
Introduction
Electronic vapor products (EVPs), including electronic cigarettes
(e-cigarettes), are battery-powered devices that heat a liquid that
typically contains nicotine and flavoring to produce an aerosol that
is inhaled by the user (1–3). The proportion of women who use
EVPs during pregnancy is unknown; however, an estimated 8% of
pregnant women in the United States smoke cigarettes, exposing
more than 320,000 fetuses annually to nicotine and other toxic-
ants (4).
Although research indicates that EVP aerosol has fewer harmful
constituents than cigarette smoke (4), EVPs and other nicotine-
containing products are not safe to use during pregnancy (5,6).
Nicotine exposure during pregnancy can contribute to increased
risk of sudden infant death syndrome, low birthweight, preterm
births, and adverse brain and lung development in fetuses and in-
fants (3,7). Additionally, some flavorings used in EVPs can be
toxic to human embryonic stem cells (8). Furthermore, although
cessation from conventional cigarettes is a commonly cited reason
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for e-cigarette use, the current scientific evidence is insufficient to
recommend use of EVPs for tobacco cessation among adults, in-
cluding pregnant women (9).
In recent  years,  EVP use has increased among US youths and
adults (10,11). National surveys indicate that female nonsmokers
and smokers are more likely than their male counterparts to exper-
iment with EVPs, and EVP use is increasing among women of re-
productive  age  and among adults  overall  aged 25  to  44  years
(10,11). Despite increased use of these products in recent years
and the risks of use during pregnancy, little is known about public
perceptions about the use of these products, particularly among
pregnant women. Some studies found that EVPs were perceived as
a safer alternative to smoking cigarettes, including during preg-
nancy (12–16). These studies were small in size and limited to
specific populations such as a university-based outpatient clinic.
Our study assessed perceptions of harm from EVP use versus ci-
garette smoking during pregnancy by using a nationally represent-
ative survey of US adults.
Methods
Data came from Styles, a series of seasonal national consumer sur-
veys  conducted  by  Porter  Novelli  (10,11).  Styles  draws  from
KnowledgePanel, an Internet panel recruited by using probability-
based sampling to reach respondents regardless of landline phone
or Internet access. Styles is conducted among a nationally repres-
entative sample of US adults aged 18 years or older. Probability-
based, stratified, random sampling is used to select panel respond-
ents. Styles was fielded June 11–29, 2015, and 4,127 participants
completed the survey, yielding a 67% response rate. Data were
weighted to 2014 Current Population Survey distributions by sex,
age, annual household income, race/ethnicity, household size, edu-
cation, US census region, metropolitan status, and Internet access
(17). Our analysis of Styles data was deemed exempt from institu-
tional review board approval because it was a secondary analysis
of de-identified data.
Perception of harm was determined by asking the question “Do
you believe it is less harmful, equally harmful, or more harmful
for  pregnant  women  to  use  electronic  vapor  products  than  to
smoke regular cigarettes?” Response options were less harmful,
equally harmful, more harmful, and don’t know.
Current cigarette smokers were defined as respondents who repor-
ted smoking at least 100 cigarettes during their lifetime and who
smoked cigarettes every day or some days at the time of the sur-
vey. Former smokers were respondents who smoked at least 100
cigarettes during their lifetime, and who smoked not at all at the
time of survey. Never smokers were respondents who smoked
fewer than 100 cigarettes in their lifetime.
Participants were asked “Have you ever tried any of the following
products, even just one time?”; to answer, respondents selected
from a list of products those they had ever used and those they had
used during the previous 30 days (“In the past 30 days, which of
the following products have you used at least once?”). EVP use
was defined on the basis of 3 response options: 1) used e-cigar-
ettes, such as Blu, 21st Century Smoke, or NJOY; 2) used electron-
ic  hookahs,  hookah  pens,  or  vape  pens,  such  as  Starbuzz  or
Fantasia; or 3) used other EVPs such as electronic cigars or elec-
tronic pipes. Current EVP users were respondents who reported
ever using EVPs, even once, and who used an EVP in the previ-
ous 30 days. Former EVP users were those who reported ever us-
ing EVPs, even once, but who had not used EVPs in the previous
30 days. Never EVP users were those who reported never using an
EVP.
Characteristics evaluated were sex, age, race/ethnicity, education,
annual household income, marital status, US census region, and
whether one or more children aged younger than 18 years lived in
the household.
Percentages and 95% confidence intervals were computed to as-
sess harm perceptions about EVP versus conventional cigarette
use by pregnant women among 3 groups: 1) all adults, 2) women
of reproductive-age (18–44 y), and 3) women of nonreproductive
age (≥45 y). We performed χ2 tests to assess differences between
harm perceptions and demographic characteristics and tobacco use
(P < .05). Additionally, for each harm perception category, pair-
wise comparisons of proportions were computed to assess differ-
ences (P < .05) between women of reproductive and women of
nonreproductive age for each sociodemographic group. Analyses
were conducted using SAS version 9.3 (SAS Institute, Inc), and
data were weighted to adjust for selection and nonresponse.
Results
Of all respondents, 14.2% were current cigarette smokers, and
5.6% were current EVP users. Among all adults, perceptions of
EVP use relative to cigarette smoking were as follows: less harm-
ful (11.1%); equally harmful (51.0%); more harmful (11.6%); and
don’t know (26.2%) (Table 1). By subpopulation, the perception
that EVP use during pregnancy was less harmful than cigarette
smoking was highest among males, adults aged 18–24 years, non-
Hispanic whites, those with less than a high school diploma, those
with an annual household income of $100,000 or more, those with
children aged younger than 18 years living in the household, cur-
rent cigarette smokers, and current EVP users.
Among reproductive aged women (18–44 y), 9.6% believed that
EVP use by pregnant women was less harmful than conventional
cigarette smoking, 59.2% believed it was equally harmful, 9.3%
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believed it was more harmful, and 21.8% reported “don’t know”
(Table 2). Among reproductive aged women, the highest percent-
age of respondents who perceived EVP use to be less harmful than
cigarette smoking was observed among those with less than a high
school diploma (12.5%) and current EVP users (31.5%).
Among nonreproductive aged women (≥45 y), 7.9% believed that
EVP use by pregnant women was less harmful than conventional
cigarette smoking, 50.9% believed it was equally harmful, 13.4%
believed it was more harmful, and 27.8% reported “don’t know.”
The highest percentage of respondents who perceived EVP use to
be less harmful than cigarette smoking was observed among His-
panics, those with less than a high school diploma, those with an-
nual  household income less than $25,000,  those with children
younger than 18 years living in the household, current cigarette
smokers, and current EVP users.
Harm perceptions differed between women of reproductive and
nonreproductive age, overall and by selected race/ethnic groups,
educational and income levels, marital status, US Census regions,
whether a child younger than 18 years lived in the household, ci-
garette smoking status, and EVP use (Table 2) (P < .05). Com-
pared with nonreproductive-aged women, the percentage of repro-
ductive-aged women who perceived EVP use during pregnancy to
be less harmful than cigarette smoking was higher among non-
Hispanic whites, non-Hispanic blacks, those with some college
education,  those  with  an  annual  household  income  less  than
$25,000, those single or married, those living in the Northeast or
Midwest, those without a child aged  younger than 18 years living
in the household, never cigarette smokers, and never EVP users (P
< .05). In contrast, compared with nonreproductive aged women,
the percentage of reproductive aged women who perceived EVP
use to be less harmful than cigarette smoking during pregnancy
was lower among high school graduates,  those with an annual
household income of $25,000 to $99,999, and those living in the
South (P < .05).
Discussion
These findings indicate that US adults have varying perceptions
about the harms of EVP use versus cigarette smoking during preg-
nancy. About half of adults studied perceived EVP use to be as
harmful as smoking, whereas over one-quarter reported they did
not know. Variations in harm perceptions were observed among
reproductive aged women (9.6%) and nonreproductive aged wo-
men  (7.9%).  Perception  of  relative  harm also  differed  by  so-
ciodemographic factors and current tobacco use. Among all adults
and among women of all ages, a higher percentage of current EVP
users than never users believed EVP use was less harmful than ci-
garette smoking. These results suggest that public health educa-
tional efforts may be warranted to inform the public about the
health risks of using all forms of tobacco during pregnancy, in-
cluding EVPs. In addition to public health messaging, clinicians
and other health care providers should ask all women of repro-
ductive age whether they are using any tobacco products, includ-
ing EVPs, and advise them of the harmful effects of using these
products during pregnancy.
EVPs are perceived as  safer  than cigarettes,  especially during
high-risk conditions such as pregnancy (12–16). A small study of
pregnant  women who attended a university’s  outpatient  clinic
found that 43% of participants believed that EVPs were less harm-
ful to a fetus than conventional cigarettes, and 57% believed that
EVPs contained nicotine (18). Among ever users of EVPs, 74%
believed that EVPs were less harmful than conventional cigarettes
(18). This perception, which could be partly due to EVP advert-
ising (19,20), could lead reproductive aged women who do not
smoke to be open to using EVPs and pregnant women who smoke
to switch to EVPs or use them to reduce cigarette smoking instead
of quitting tobacco use entirely (15).
Although current research indicates that EVP aerosol has fewer
harmful constituents than conventional cigarette smoke, EVP use
during pregnancy is not risk-free (3,5–7). One concern with EVP
use  during  pregnancy,  with  or  without  concurrent  cigarette
smoking, is that many EVP products contain nicotine (3,7). The
US Surgeon General has concluded that evidence is sufficient to
warn pregnant women and those of reproductive age about the
harmful effects of using any nicotine products during pregnancy
(1).
This study has limitations. First, although Styles uses an address-
based probability sample of the US population, certain popula-
tions are less likely to respond. However, Styles data are weighted
to be nationally representative, and tobacco use estimates from
Styles are consistent with other national household surveys (21).
Second, because of the questions on the Styles survey, former
EVP use was ascertained by using ever use as a threshold for regu-
lar  use.  Given that  it  was  not  possible  to  distinguish  between
former EVP users who routinely used the products and those who
only briefly experimented with the products, this classification
could introduce bias. Third, the sensitive nature of the questions
may have led some participants to provide more socially accept-
able responses rather than provide their true perception. However,
given that the survey was completed on the Internet, the likeli-
hood of such bias is probably minimal (22).
This study found that a higher percentage of reproductive aged
women than nonreproductive aged women believed EVP use was
less harmful than cigarette smoking, overall and by sociodemo-
graphic characteristics and tobacco use status. A higher percent-
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age of EVP users than never EVP users believed EVP use was less
harmful than conventional cigarette smoking. These findings have
several implications for public health policy, planning, and prac-
tice. First, when addressing potential public health harms associ-
ated with EVP use, proven strategies should be implemented to
prevent and reduce all forms of tobacco use, including tobacco
price increases, comprehensive smoke-free laws, high-impact me-
dia campaigns, barrier-free cessation treatment and services, and
comprehensive statewide tobacco control programs (1). A compre-
hensive approach can reduce the use of all tobacco products, in-
cluding by pregnant women. Second, clinicians and other health
care providers should ask all women of reproductive age whether
they are using any tobacco products, including EVPs, and advise
them about  the  harmful  effects  of  using products  that  contain
nicotine and other toxicants during pregnancy. Finally, efforts are
warranted 1) to educate the public, particularly cigarette smokers
and EVP users, about the health risks of EVP use during preg-
nancy, 2) to provide advice and assistance to those who want to
quit, and 3) to promote quitting all forms of tobacco use.
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Tables
Table 1. Perceptions About Harmful Effects of Electronic Vapor Products (EVPs) Versus Cigarette Smoking During Pregnancya Among Adults Aged 18 Years or Older
(N = 4,127), by Sociodemographic Characteristics, Styles Survey, United States, 2015
Characteristic
All Adults aged ≥18 years
Less Harmful
% (95%CI)
Equally Harmful
% (95%CI)
More Harmful
% (95%CI)
Do Not Know
% (95%CI)
Overall 11.1 (10.0–12.3) 51.0 (49.2–52.8) 11.6 (10.4–12.8) 26.2 (24.6–27.8)
Sex
Female 8.7 (7.2–10.1)b 54.7 (52.2–57.1) 11.5 (9.9–13.2) 25.1 (23.0–27.2)
Male 13.8 (12.0–15.6) 47.1 (44.5–49.8) 11.7 (9.9–13.5) 27.4 (25.0–29.7)
Age
18–24 15.4 (10.7–20.0)b 52.3 (46.1–58.4) 10.3 (6.5–14.1) 22.1 (17.0–27.1)
25–44 10.7 (8.8–12.7) 53.9 (50.5–57.2) 10.9 (8.6–13.1) 24.5 (21.7–27.4)
45–64 11.8 (10.0–13.5) 48.7 (46.0–51.4) 11.6 (9.8–13.5) 27.9 (25.5–30.3)
≥ 65 7.9 (5.9–10.0) 49.5 (45.7–53.2) 13.9 (11.2–16.5) 28.7 (25.3–32.1)
Race/ethnicity
Non-Hispanic white 12.7 (11.3–14.0)b 52.1 (50.0–54.1) 8.0 (6.9–9.1) 27.3 (25.5–29.1)
Non-Hispanic black 8.7 (5.6–11.8) 40.1 (34.6–45.5) 22.5 (18.0–27.5) 28.5 (23.4–33.6)
Hispanic 8.6 (5.3–11.8) 51.6 (46.2–56.9) 15.4 (11.5–19.3) 24.5 (19.3–29.0)
Non-Hispanic other 6.8 (2.9–10.7) 57.9 (49.7–66.0) 18.6 (12.0–25.2) 16.7 (10.6–22.9)
Education
<High school diploma 12.9 (8.5–17.3)b 39.8 (33.6–12.3) 16.9 (12.2–21.6) 30.3 (24.4–36.3)
High school graduate 10.4 (8.5–12.3) 50.1 (46.9–53.4) 12.1 (9.8–14.3) 27.4 (24.6–30.2)
Some college 10.6 (8.6–12.7) 52.4 (49.1–55.6) 11.8 (9.7–14.0) 25.2 (22.4–28.0)
College degree or more 11.6 (9.7–13.6) 55.3 (52.2–58.4) 8.8 (6.9–10.7) 24.2 (21.6–26.9)
Annual household income, $
<25,000 11.9 (9.1–14.7)b 40.9 (36.7–45.1) 15.4 (12.1–18.7) 31.8 (27.8–35.7)
Abbreviation: CI, confidence interval.
a “Perception of harm” was categorized as “less harmful,” “equally harmful,” “more harmful,” or “don’t know” on the basis of responses to the question “Do you be-
lieve it is less harmful, equally harmful, or more harmful for pregnant women to use electronic vapor products than to smoke regular cigarettes?” Missing data were
excluded from the analysis for cigarette smoking status (2.7%), EVP use status (0.5%), and whether a child under age 18 was living in the household (0.3%).
b Significant χ2 test (P < .05) indicated difference across groups within the specified characteristic.
c Northeast: Connecticut, Maine, Massachusetts, New Jersey, New Hampshire, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa,
Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia,
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West:
Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
d Defined as responding yes to having at least one child younger than 18 years living in the household.
e Current cigarette smokers were defined as respondents who reported smoking at least 100 cigarettes during their lifetime and who currently smoked cigarettes
every day or some days. Former smokers were defined as respondents who reported having smoked at least 100 cigarettes in a lifetime, and who reported
smoking not at all at the time of survey. Never cigarette smokers were defined as respondents who reported not having smoked 100 cigarettes in their lifetime.
f Current EVP users were defined as respondents who reported using any of the following products in their lifetime and within the previous 30 days: electronic cigar-
ettes, such as Blu, 21st Century Smoke, or NJOY; electronic hookahs, hookah pens, or vape pens, such as Starbuzz or Fantasia; or some other electronic vapor
product such as electronic cigars or electronic pipes. Former EVP users were defined as respondents who reported using EVPs at least once in their lifetime, and
who reported not using EVPs in the past 30 days. Never EVP users were defined as respondents who reported not using EVPs in their lifetime and not using EVPs in
the past 30 days.
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 13, E175
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY   DECEMBER 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
6       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/16_0349.htm
(continued)
Table 1. Perceptions About Harmful Effects of Electronic Vapor Products (EVPs) Versus Cigarette Smoking During Pregnancya Among Adults Aged 18 Years or Older
(N = 4,127), by Sociodemographic Characteristics, Styles Survey, United States, 2015
Characteristic
All Adults aged ≥18 years
Less Harmful
% (95%CI)
Equally Harmful
% (95%CI)
More Harmful
% (95%CI)
Do Not Know
% (95%CI)
25,000–49,999 8.1 (6.2–9.8) 49.0 (45.4–52.5) 14.9 (12.2–17.5) 28.1 (24.9–31.4)
50,000–99,999 10.9 (8.9–12.9) 53.1 (50.0–56.2) 10.2 (8.2–12.2) 25.8 (23.1–28.5)
≥100,000 13.7 (11.2–16.3) 57.4 (53.7–61.1) 7.9 (5.8–10.1) 20.9 (17.9–23.9)
Marital status
Married/living with partner 11.1 (9.8–12.5) 52.0 (49.7–54.2) 11.1 (9.6–12.6) 25.8 (23.8–27.7)
Single 12.4 (9.8–15.1) 50.6 (46.6–54.5) 11.9 (9.3–14.5) 25.2 (21.8–28.5)
Divorced/widowed/separated 8.6 (6.2–10.9) 47.9 (43.4–52.3) 13.5 (10.3–16.6) 30.1 (25.9–34.3)
US census regionc
Northeast 11.8 (9.0–14.6) 49.4 (45.2–53.6) 10.0 (7.4–12.6) 28.8 (25.0–32.6)
Midwest 13.3 (10.9–15.8) 51.5 (48.0–55.0) 8.7 (6.8–10.6) 26.5 (23.4–29.5)
South 10.6 (8.7–12.5) 49.2 (46.2–52.2) 12.8 (10.6–14.9) 27.4 (24.7–30.1)
West 9.5 (7.2–11.7) 54.9 (51.0–58.7) 13.7 (10.9–16.6) 22.0 (18.8–25.1)
Children <18 years living in householdd
Yes 11.7 (9.5–13.8b 55.2 (51.8–58.5) 9.7 (7.7–11.8) 23.4 (20.5–26.3)
No 11.0 (9.6–12.3) 49.6 (47.5–51.7) 12.4 (10.9–13.9) 27.1 (25.2–28.9)
Cigarette smoking statuse
Never smoker 10.0 (8.5–11.5)b 52.6 (50.2–55.0) 12.0 (10.4–13.6) 25.4 (23.3–27.5)
Current smoker 16.8 (13.2–20.3) 44.9 (39.9–49.8) 10.5 (7.1–13.8) 27.9 (23.5–32.3)
Former smoker 11.7 (9.6–13.8) 52.6 (49.3–55.8) 10.7 (8.6–12.8) 25.0 (22.2–27.8)
EVP usef
Never user 9.1 (7.9–10.2)b 52.5 (50.5–54.4) 12.2 (10.9–13.6) 26.3 (24.6–28.0)
Current user 36.8 (28.7–45.0) 28.2 (20.8–35.5) 8.0 (3.4–12.7) 27.0 (19.1–34.8)
Former user 16.9 (12.9–20.9) 51.1 (45.4–56.8) 8.5 (5.4–11.7) 23.4 (18.7–28.2)
Abbreviation: CI, confidence interval.
a “Perception of harm” was categorized as “less harmful,” “equally harmful,” “more harmful,” or “don’t know” on the basis of responses to the question “Do you be-
lieve it is less harmful, equally harmful, or more harmful for pregnant women to use electronic vapor products than to smoke regular cigarettes?” Missing data were
excluded from the analysis for cigarette smoking status (2.7%), EVP use status (0.5%), and whether a child under age 18 was living in the household (0.3%).
b Significant χ2 test (P < .05) indicated difference across groups within the specified characteristic.
c Northeast: Connecticut, Maine, Massachusetts, New Jersey, New Hampshire, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa,
Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia,
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West:
Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
d Defined as responding yes to having at least one child younger than 18 years living in the household.
e Current cigarette smokers were defined as respondents who reported smoking at least 100 cigarettes during their lifetime and who currently smoked cigarettes
every day or some days. Former smokers were defined as respondents who reported having smoked at least 100 cigarettes in a lifetime, and who reported
smoking not at all at the time of survey. Never cigarette smokers were defined as respondents who reported not having smoked 100 cigarettes in their lifetime.
f Current EVP users were defined as respondents who reported using any of the following products in their lifetime and within the previous 30 days: electronic cigar-
ettes, such as Blu, 21st Century Smoke, or NJOY; electronic hookahs, hookah pens, or vape pens, such as Starbuzz or Fantasia; or some other electronic vapor
product such as electronic cigars or electronic pipes. Former EVP users were defined as respondents who reported using EVPs at least once in their lifetime, and
who reported not using EVPs in the past 30 days. Never EVP users were defined as respondents who reported not using EVPs in their lifetime and not using EVPs in
the past 30 days.
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Table 2. Perception of Harmful Effects of Electronic Vapor Products (EVPs) Versus Cigarette Smoking During Pregnancya Among Women Of Reproductive Age
(18–44 y) and Women of Nonreproductive Age (≥45 y), by Sociodemographic Characteristics, Styles Survey, United States, 2015
Characteristic
Women of Reproductive Age (n = 820) Women of Nonreproductive Age (n = 1,398)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
Overall 9.6 (7.2–12.1)b 59.2
(55.3–63.2)
9.3 (6.9–11.7) 21.8
(18.5–25.2)
7.9 (6.2–9.5) 50.9
(47.9–53.9)
13.4
(11.2–15.6)
27.8
(25.1–30.5)
Race/ethnicity
Non-Hispanic white 10.8
(7.7–13.9)b
59.6
(54.8–64.4)
6.2 (4.0–8.4) 23.4
(19.2–27.6)
8.4 (6.5–10.3)c 53.3
(50.0–56.5)
10.0 (7.9–12.1) 28.3
(25.4–31.3)
Non-Hispanic black 7.2 (0.5–14.0b 53.3
(41.2–65.5)
19.6 (9.8–29.4) 19.8
(10.4–29.3)
4.5 (1.1–7.8) 39.6
(30.1–49.1)
28.4
(19.3–37.4)
27.6
(18.9–36.3)
Hispanic 8.6 (2.3–14.8) 57.9
(47.8–68.0)
11.3 (4.6–17.9) 22.3
(13.8–30.8)
9.6 (2.1–17.1) 45.3
(34.5–56.2)
18.2 (9.9–26.4) 26.9
(17.0–36.8)
Non-Hispanic other 7.2 (0.1–14.3) 65.4
(51.3–79.4)
12.8 (2.3–23.3) 14.6 (4.5–24.7) 4.4 (0-10.9) 54.0
(36.9–71.2)
18.7 (4.6–32.7) 22.9 (7.8–38.0)
Education
<High school diploma 12.5
(2.4–22.7)c
43.0
(28.4–57.5)
10.1 (2.1–18.0) 34.4
(20.3–48.6)
11.8
(3.9–19.7)c
32.4
(21.7–43.1)
18.8 (9.9–27.7) 37.0
(25.6–48.5)
High school graduate 6.6 (2.4–10.9)b 60.9
(52.2–69.6)
10.3 (4.0–16.6) 22.2
(15.2–29.1)
7.9 (5.0–10.8) 48.4
(43.4–53.3)
14.4
(10.9–18.0)
29.3
(24.7–33.9)
Some college 10.7
(6.2–15.2)b
59.1
(52.3–65.8)
12.9 (8.3–17.5) 17.3
(12.3–22.4)
7.8 (4.9–10.6) 53.8
(48.4–59.3)
12.5 (8.3–16.6) 25.9
(21.3–30.6)
College degree or
more
9.5 (5.8–13.2) 63.5
(57.3–69.7)
5.1 (2.4–7.8) 21.9
(16.5–27.4)
6.2 (4.0–8.5) 59.1
(53.7–64.4)
10.8 (6.7–14.9) 23.9
(19.5–28.3)
Annual household income, $
<25,000 14.6
(3.5–25.8)b
50.0
(36.7–63.3)
11.0 (4.2–17.7) 24.4
(13.7–35.1)
10.2
(5.3–15.1)c
41.2
(33.6–48.7)
14.3 (8.8–19.8) 34.3
(26.7–41.9)
25,000–49,999 6.5 (3.6–9.4)b 59.6
(52.4–66.8)
9.5 (5.4–13.6) 24.3
(17.7–30.9)
7.1 (4.0–10.2) 45.6
(39.9–51.3)
19.3
(14.4–24.2)
28.0
(22.9–33.1)
50,000–99,999 7.6 (4.1–11.1)b 61.5
(55.1–67.8)
11.2 (6.7–15.6) 19.8
(14.6–24.9)
8.0 (5.2–10.8) 52.1
(47.0–57.2)
11.9 (8.2–15.7) 28.0
(23.5–32.5)
Abbreviation: CI, confidence interval.
a “Perception of harm” was categorized as “less harmful,” “equally harmful,” “more harmful,” or “don’t know” on the basis of responses to the question “Do you be-
lieve it is less harmful, equally harmful, or more harmful for pregnant women to use electronic vapor products than to smoke regular cigarettes?” A total of 30
cases (3.6%) were excluded from the multivariate model due missing data for at least one of the assessed variables.
b Significant χ2 test (P < .05) indicated difference across groups within the specified characteristic
c Significant test of difference in proportions (P < .05) between women of reproductive age and women of non-reproductive age for each characteristic.
d Northeast: Connecticut, Maine, Massachusetts, New Jersey, New Hampshire, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana,
Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia;
West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
e Defined as responding yes to having at least one child less than 18 years of age living in the household.
f Current cigarette smokers were defined as respondents who reported smoking at least 100 cigarettes during their lifetime and who currently smoked cigarettes
“every day” or “some days”. Former smokers were defined as respondents who reported having smoked at least 100 cigarettes in a lifetime, and who reported
smoking “not at all” at the time of survey. Never cigarette smokers were defined as respondents who reported not having smoked 100 cigarettes in their lifetime.
g Current EVP users were defined as respondents who reported having used any of the following products within the past 30 days: electronic cigarettes, such as
Blu, 21st Century Smoke, or NJOY; electronic hookahs, hookah pens, or vape pens, such as Starbuzz or Fantasia; or some other electronic vapor product such as
electronic cigars or electronic pipes. Former EVP users were defined as respondents who reported using EVPs at least once but who reported not using EVPs in the
previous 30 days. Never EVP users were defined as respondents who reported never having used EVPs.
(continued on next page)
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Table 2. Perception of Harmful Effects of Electronic Vapor Products (EVPs) Versus Cigarette Smoking During Pregnancya Among Women Of Reproductive Age
(18–44 y) and Women of Nonreproductive Age (≥45 y), by Sociodemographic Characteristics, Styles Survey, United States, 2015
Characteristic
Women of Reproductive Age (n = 820) Women of Nonreproductive Age (n = 1,398)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
≥100,000 13.7 (8.0–19.4) 58.8
(50.5–67.1)
5.7 (1.4–10.0) 21.8
(14.8–28.8)
6.7 (3.7–9.7) 63.0
(57.0–69.0)
8.3 (4.5–12.1) 22.1
(17.0–27.1)
Marital status
Married/living with
partner
8.8 (6.0–11.6)b 58.6
(53.5–63.6)
10.3 (6.9–13.6) 22.4
(18.1–26.6)
7.5 (5.5–9.5) 52.0
(48.2–55.8)
12.5 (9.8–15.3) 27.9
(24.6–31.3)
Single 11.4
(6.6–16.1)b
62.0
(55.1–68.8)
6.8 (3.3–10.3) 19.9
(14.3–25.5)
10.9 (3.8–17.9) 44.5
(34.8–54.1)
16.6 (9.2–24.0) 28.1
(19.9–36.2)
Divorced/widowed/
separated
5.9 (0-12.2) 46.3
(29.4–63.1)
17.4 (5.1–29.7) 30.4
(14.4–46.3)
7.6 (4.6–10.6) 50.7
(44.9–56.6)
14.3
(10.0–18.6)
27.3
(21.9–32.8)
US census regiond
Northeast 14.1
(6.7–21.6)b
55.6
(45.9–65.3)
6.7 (1.5–11.9) 23.6
(15.5–31.7)
9.9 (5.7–14.2) 48.4
(41.5–55.3)
10.5 (5.8–15.2) 31.2
(24.7–37.6)
Midwest 12.9
(7.1–18.7)b
60.8
(52.7–68.9)
6.0 (2.6–9.4) 20.3
(13.5–27.1)
7.3 (4.3–10.2) 52.7
(47.1–58.2)
12.1 (8.2–16.0) 28.0
(23.0–33.0)
South 8.2 (4.3–12.1)b 58.8
(52.1–65.6)
10.2 (6.0–14.4) 22.8
(16.9–28.6)
9.2 (6.2–12.3) 48.2
(43.1–53.2)
14.3
(10.4–18.1)
28.3
(23.9–32.9)
West 5.9 (2.3–9.3) 60.8
(52.8–68.8)
12.6 (6.9–18.3) 20.7 (14.2–7.3) 4.1 (1.4–6.7) 56.5
(49.3–63.7)
16.0
(10.4–21.7)
23.4
(17.1–29.7)
Children <18 years living in householde
Yes 8.6 (5.7–11.6) 58.8
(53.5–64.1)
9.1 (5.9–12.2) 23.5
(18.8–28.1)
13.5
(7.4–19.6)c
48.0
(41.0–55.0)
14.1 (8.4–19.8) 24.4
(18.3–30.6)
No 10.7
(6.7–14.6)b
59.7
(53.7–65.7)
9.6 (5.9–13.3) 20.0
(15.2–24.9)
7.0 (5.4–8.7) 51.6
(48.2–54.8)
13.4
(10.9–15.8)
28.1
(25.1–31.0)
Cigarette smoking statusf
Never smoker 9.4 (6.5–12.4)b 61.4
(56.7–66.1)
8.5 (5.8–11.1) 20.7
(16.7–24.6)
5.0 (3.2–6.8)c 52.0
(47.8–56.1)
14.9
(11.7–18.0)
28.2
(24.4–31.9)
Current smoker 11.9 (4.7–19.1) 55.4 10.2 (1.7–18.7) 22.5 20.7 40.5 10.1 (3.9–16.3) 28.7
Abbreviation: CI, confidence interval.
a “Perception of harm” was categorized as “less harmful,” “equally harmful,” “more harmful,” or “don’t know” on the basis of responses to the question “Do you be-
lieve it is less harmful, equally harmful, or more harmful for pregnant women to use electronic vapor products than to smoke regular cigarettes?” A total of 30
cases (3.6%) were excluded from the multivariate model due missing data for at least one of the assessed variables.
b Significant χ2 test (P < .05) indicated difference across groups within the specified characteristic
c Significant test of difference in proportions (P < .05) between women of reproductive age and women of non-reproductive age for each characteristic.
d Northeast: Connecticut, Maine, Massachusetts, New Jersey, New Hampshire, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana,
Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia;
West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
e Defined as responding yes to having at least one child less than 18 years of age living in the household.
f Current cigarette smokers were defined as respondents who reported smoking at least 100 cigarettes during their lifetime and who currently smoked cigarettes
“every day” or “some days”. Former smokers were defined as respondents who reported having smoked at least 100 cigarettes in a lifetime, and who reported
smoking “not at all” at the time of survey. Never cigarette smokers were defined as respondents who reported not having smoked 100 cigarettes in their lifetime.
g Current EVP users were defined as respondents who reported having used any of the following products within the past 30 days: electronic cigarettes, such as
Blu, 21st Century Smoke, or NJOY; electronic hookahs, hookah pens, or vape pens, such as Starbuzz or Fantasia; or some other electronic vapor product such as
electronic cigars or electronic pipes. Former EVP users were defined as respondents who reported using EVPs at least once but who reported not using EVPs in the
previous 30 days. Never EVP users were defined as respondents who reported never having used EVPs.
(continued on next page)
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Table 2. Perception of Harmful Effects of Electronic Vapor Products (EVPs) Versus Cigarette Smoking During Pregnancya Among Women Of Reproductive Age
(18–44 y) and Women of Nonreproductive Age (≥45 y), by Sociodemographic Characteristics, Styles Survey, United States, 2015
Characteristic
Women of Reproductive Age (n = 820) Women of Nonreproductive Age (n = 1,398)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
Less Harmful,
% (95% CI)
Equally
Harmful, %
(95% CI)
More Harmful,
% (95% CI)
Don't Know, %
(95% CI)
(43.4–67.4) (13.3–31.8) (13.3–28.1) (32.0–49.0) (21.3–36.1)
Former smoker 10.7 (4.5–16.8) 52.4
(42.3–62.5)
12.8 (5.4–20.3) 24.1
(15.3–32.8)
7.7 (5.0–10.5) 54.1
(48.9–59.4)
12.1 (8.5–15.7) 26.0
(21.4–30.6)
EVP useg
Never user 8.7
(6.1–11.3)b,c
60.0
(55.6–64.4)
9.9 (7.1–12.7) 21.3
(17.7–25.0)
5.5 (4.0–7.1)c 53.1
(49.9–56.4)
14.0
(11.6–16.4)
27.4
(24.5–30.3)
Current user 31.5
(13.7–49.3)
33.4
(16.3–50.5)
5.4 (0–15.5) 29.7
(12.7–46.8)
32.8
(19.8–30.4)
24.2
(11.7–36.7)
10.8 (0.3–21.3) 32.2
(17.8–46.5)
Former user 8.4 (2.6–14.3) 64.5
(54.3–74.7)
7.4 (2.9–12.0) 19.6
(10.9–28.3)
21.6
(12.8–30.4)
40.8
(30.1–51.4)
8.5 (1.2–15.9) 29.1
(20.0–38.3)
Abbreviation: CI, confidence interval.
a “Perception of harm” was categorized as “less harmful,” “equally harmful,” “more harmful,” or “don’t know” on the basis of responses to the question “Do you be-
lieve it is less harmful, equally harmful, or more harmful for pregnant women to use electronic vapor products than to smoke regular cigarettes?” A total of 30
cases (3.6%) were excluded from the multivariate model due missing data for at least one of the assessed variables.
b Significant χ2 test (P < .05) indicated difference across groups within the specified characteristic
c Significant test of difference in proportions (P < .05) between women of reproductive age and women of non-reproductive age for each characteristic.
d Northeast: Connecticut, Maine, Massachusetts, New Jersey, New Hampshire, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana,
Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia;
West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
e Defined as responding yes to having at least one child less than 18 years of age living in the household.
f Current cigarette smokers were defined as respondents who reported smoking at least 100 cigarettes during their lifetime and who currently smoked cigarettes
“every day” or “some days”. Former smokers were defined as respondents who reported having smoked at least 100 cigarettes in a lifetime, and who reported
smoking “not at all” at the time of survey. Never cigarette smokers were defined as respondents who reported not having smoked 100 cigarettes in their lifetime.
g Current EVP users were defined as respondents who reported having used any of the following products within the past 30 days: electronic cigarettes, such as
Blu, 21st Century Smoke, or NJOY; electronic hookahs, hookah pens, or vape pens, such as Starbuzz or Fantasia; or some other electronic vapor product such as
electronic cigars or electronic pipes. Former EVP users were defined as respondents who reported using EVPs at least once but who reported not using EVPs in the
previous 30 days. Never EVP users were defined as respondents who reported never having used EVPs.
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